“It’s use in clinical practice may contribute to better knowledge of the local epidemiology of Beta-lactam resistance genes and to more appropriate use of antimicrobial agents, reduction of costs, and improved patient outcome.”
- Microarrays for Carbapenemases, ESBLs, and AmpCs
- Improve your epidemiological insight
- Investigate suspected multidrug resistance
- Exclude outbreaks
[lead]Molecular detection of Beta-lactamase in Gram negative bacilli[/lead]
- Carbapenemases
- KPC, NDM, VM, IMP, OXA-48 LIKE, GES, GIM, SPM, OXA-23 LIKE, OXA-24 LIKE, OXA-58 LIKE
- CTX-M ESBLs
- CTX-M-1 group, CTX-M-1-like, CTX-M-15-like, CTX-M-3-like
- CTX-M-32-like, CTX-M-2 group, CTX-M-8 & -25 group, CTX M-9 group
- TEM ESBLs vs. non-ESBL
- TEM wt, TEM E104k, TEM R164S, TEM R164C, TEM R164H, TEM G238S
- SHV ESBLs vs non-ESBL
- SHV wt, SHV G238S, SHV G238A, SHV E240K
- Other ESBLs
- VEB, PER, BEL, GES
- AmpCs
- CMY I/MOX, ACC, DHA, ACT/MIR, CMY ll, FOX